stockrow
Friday 6 November 2026
Export ISRG’s income statement to Excel — free account
Intuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.
- Revenue
- +21.7%
- EPS
- −24.2%
- Free cash flow
- +51.0%
Quarter to September 2026, against a year earlier
465.68
16.42
−3.41%
Follow ISRG
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
33.51 | 63.45 | 48.23 | 49.43 | 90.30 | 75.06 | 71.41 | 64.77 | 79.93 | 70.71 |
Piotroski F-Score |
6 | 7 | 7 | 4 | 5 | 7 | 6 | 8 | 6 | 7 |
Altman Z-Score |
22.28 | 26.17 | 29.97 | 29.99 | 42.47 | 49.65 | 32.13 | 36.53 | 51.96 | 50.09 |
P/S ratio |
9.08 | 13.36 | 14.62 | 15.23 | 21.97 | 22.41 | 15.19 | 16.32 | 22.20 | 20.08 |
P/FCF ratio |
23.79 | 43.97 | 55.44 | 58.18 | 83.74 | 73.12 | 98.59 | 155.07 | 142.20 | 81.16 |
Altman Z″-Score (non-manufacturers) |
13.01 | 8.78 | 10.65 | 10.24 | 12.18 | 12.15 | 10.41 | 11.30 | 11.74 | 12.06 |
Beneish M-Score |
(2.66) | (2.78) | (2.25) | (2.55) | (2.71) | (2.15) | (2.53) | (2.35) | (2.17) | (2.43) |
P/Operating CF |
74.55 | 126.25 | 161.06 | 123.43 | 152.58 | 225.38 | 215.77 | 509.16 | 225.38 | 226.48 |
P/B ratio |
4.25 | 8.77 | 8.14 | 8.23 | 9.81 | 10.71 | 8.50 | 8.68 | 11.22 | 11.27 |
Price to Tangible BV |
4.41 | 9.56 | 8.80 | 9.05 | 10.74 | 11.66 | 9.40 | 9.37 | 12.03 | 12.09 |
EV/Sales |
8.14 | 12.73 | 13.80 | 14.51 | 20.80 | 21.67 | 14.52 | 15.58 | 21.72 | 19.49 |
EV/EBITDA |
20.94 | 34.06 | 38.56 | 40.86 | 67.48 | 57.19 | 45.88 | 49.97 | 63.68 | 54.16 |
EV/Operating CF |
20.26 | 34.93 | 43.94 | 40.67 | 61.04 | 59.22 | 60.62 | 61.21 | 75.11 | 64.74 |
EV/FCF |
21.32 | 41.92 | 52.32 | 55.43 | 79.27 | 70.71 | 94.29 | 148.10 | 139.12 | 78.77 |
Quick Ratio |
5.00 | 3.72 | 4.56 | 3.75 | 5.96 | 4.34 | 3.56 | 3.83 | 3.00 | 3.72 |
Current Ratio |
5.45 | 4.24 | 5.28 | 4.53 | 6.86 | 5.08 | 4.40 | 4.76 | 4.07 | 4.87 |
Net Debt/EBITDA |
(2.43) | (1.67) | (2.30) | (2.03) | (3.81) | (1.94) | (2.09) | (2.35) | (1.41) | (1.64) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.48 | 0.51 | 0.55 | 0.51 | 0.42 | 0.46 | 0.47 | 0.50 | 0.49 | 0.51 |
Operating CF/Net income |
1.47 | 1.71 | 1.04 | 1.16 | 1.40 | 1.23 | 1.13 | 1.01 | 1.04 | 1.06 |
Capex/Depreciation |
(0.53) | (1.73) | (1.40) | (1.97) | (1.16) | (0.99) | (1.36) | (2.34) | (2.22) | (0.80) |
| 14.62% | 12.71% | 19.67% | 18.42% | 11.76% | 15.70% | 11.47% | 14.67% | 15.52% | 16.57% | |
| 12.96% | 10.94% | 16.56% | 15.69% | 10.15% | 13.79% | 9.97% | 12.66% | 13.59% | 14.57% | |
ROIC |
18.42% | 23.56% | 20.68% | 16.97% | 14.12% | 14.69% | 14.09% | 13.51% | 11.73% | 15.33% |
Return on Tangible Assets |
23.72% | 24.32% | 26.08% | 28.12% | 14.65% | 25.94% | 18.35% | 18.41% | 23.20% | 21.78% |
Average Days of Receivables |
58.02 | 59.07 | 66.87 | 52.58 | 54.06 | 50.03 | 55.26 | 57.91 | 53.55 | 55.39 |
Research and Development Expense of Revenue |
8.85% | 10.47% | 11.23% | 12.44% | 13.65% | 11.75% | 14.13% | 14.02% | 13.71% | 13.03% |
Selling, General and Administrative Expense of Revenue |
26.00% | 25.83% | 26.49% | 26.31% | 27.91% | 25.68% | 27.96% | 27.57% | 25.62% | 23.70% |
Intangible Assets out of Total Assets |
0.03 | 0.07 | 0.06 | 0.08 | 0.08 | 0.07 | 0.08 | 0.06 | 0.06 | 0.06 |
Share Based Compensation of Revenue |
6.56% | 6.66% | 7.01% | 7.50% | 9.07% | 7.87% | 8.25% | 8.32% | 8.10% | 7.83% |
Graham Net Nets |
0.10 | 0.04 | 0.06 | 0.05 | 0.05 | 0.03 | 0.05 | 0.05 | 0.03 | 0.04 |
Graham Number |
28.33 | 25.15 | 38.21 | 46.33 | 43.46 | 60.12 | 51.14 | 66.23 | 82.69 | 95.18 |
Earnings Yield |
2.98% | 1.58% | 2.07% | 2.02% | 1.11% | 1.33% | 1.40% | 1.54% | 1.25% | 1.41% |
Free Cash Flow Yield |
4.20% | 2.27% | 1.80% | 1.72% | 1.19% | 1.37% | 1.01% | 0.64% | 0.70% | 1.23% |
Revenue per Share |
7.85 | 9.37 | 10.92 | 12.94 | 12.41 | 16.04 | 17.49 | 20.29 | 23.51 | 28.20 |
Operating CF per Share |
3.15 | 3.41 | 3.43 | 4.62 | 4.23 | 5.87 | 4.19 | 5.16 | 6.80 | 8.49 |
Capex per Share |
(0.16) | (0.57) | (0.55) | (1.23) | (0.97) | (0.95) | (1.50) | (3.03) | (3.13) | (1.51) |
Free Cash Flow per Share |
3.00 | 2.84 | 2.88 | 3.39 | 3.26 | 4.91 | 2.69 | 2.13 | 3.67 | 6.98 |
Cash per Share |
7.41 | 5.85 | 8.98 | 9.31 | 14.56 | 11.81 | 11.58 | 14.87 | 11.30 | 16.63 |
Shareholders Equity per Share |
16.76 | 14.27 | 19.61 | 23.93 | 27.80 | 33.56 | 31.24 | 38.15 | 46.54 | 50.27 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
16.76 | 14.27 | 19.61 | 23.93 | 27.80 | 33.56 | 31.24 | 38.15 | 46.54 | 50.27 |
Free Cash Flow |
1,033.10 | 953.20 | 982.20 | 1,172.60 | 1,143.30 | 1,749.90 | 958.40 | 749.60 | 1,303.80 | 2,490.70 |
Working Capital |
2,653.90 | 2,146.10 | 3,512.60 | 3,632.40 | 5,660.70 | 4,695.10 | 4,830.90 | 6,229.30 | 5,365.70 | 7,773.30 |
Capital Expenditures |
(53.90) | (190.70) | (187.40) | (425.60) | (341.50) | (339.50) | (532.40) | (1,064.20) | (1,111.20) | (539.80) |
Net Current Asset Value |
2,541.30 | 1,812.50 | 3,174.00 | 3,214.10 | 5,216.10 | 4,241.40 | 4,391.60 | 5,843.80 | 4,897.40 | 7,262.50 |
EV/EBIT |
23.19 | 37.59 | 42.85 | 47.29 | 86.33 | 67.95 | 57.30 | 62.84 | 77.22 | 66.61 |
Capex to Sales |
0.02 | 0.06 | 0.05 | 0.10 | 0.08 | 0.06 | 0.09 | 0.15 | 0.13 | 0.05 |
Price to Operating Income |
25.88 | 39.43 | 45.40 | 49.63 | 91.20 | 70.26 | 59.91 | 65.79 | 78.93 | 68.62 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.22 | 0.18 | 0.16 | 0.17 | 0.19 | 0.18 | 0.17 | 0.13 | 0.11 | 0.13 |
Cash ROIC |
12.40% | 14.14% | 10.07% | 10.19% | 7.69% | 10.83% | 6.29% | 4.03% | 6.35% | 10.43% |
Accounts Receivable Turnover |
6.57 | 6.69 | 6.26 | 6.75 | 6.75 | 8.00 | 7.22 | 6.88 | 7.09 | 7.31 |
Accounts Payable Turnover |
13.44 | 12.40 | 12.23 | 12.21 | 14.60 | 17.27 | 15.11 | 14.27 | 14.23 | 15.26 |
Inventory Turnover |
4.65 | 4.42 | 3.45 | 2.72 | 2.50 | 2.95 | 2.74 | 2.27 | 2.01 | 2.06 |
Average Days of Payables |
30.73 | 32.16 | 32.81 | 32.94 | 19.89 | 25.26 | 26.48 | 28.76 | 25.97 | 27.21 |
Days of Inventory on Hand |
81.78 | 94.04 | 133.28 | 158.85 | 146.64 | 122.34 | 160.90 | 186.05 | 199.72 | 196.24 |
Average Receivables |
412.25 | 469.05 | 595.10 | 663.75 | 645.35 | 714.10 | 862.40 | 1,036.15 | 1,177.80 | 1,376.35 |
Average Payables |
60.55 | 75.50 | 91.60 | 112.10 | 102.55 | 101.40 | 134.10 | 167.85 | 191.05 | 224.25 |
Average Inventory |
175.10 | 211.75 | 325.10 | 502.25 | 598.50 | 594.30 | 740.15 | 1,056.90 | 1,353.90 | 1,663.60 |
Average Assets |
5,697.10 | 6,131.85 | 6,811.75 | 8,789.95 | 10,451.05 | 12,361.95 | 13,264.50 | 14,207.75 | 17,092.35 | 19,600.95 |
Average Common Equity |
5,048.65 | 5,279.10 | 5,733.95 | 7,486.10 | 9,021.90 | 10,855.30 | 11,532.05 | 12,254.95 | 14,963.45 | 17,235.65 |
Columns are period end dates · fundamentals updated 2 Nov 2026